Related Experiment Video
Updated: Aug 4, 2025

A Unified Methodological Framework for Vestibular Schwannoma Research
Published on: June 20, 2017
Cochlear Implantation in Sporadic Vestibular Schwannoma and Neurofibromatosis Type II
Fiona McClenaghan1, Simon Freeman1, Simon Lloyd2
1Department of ENT, Salford Royal Hospital, Stott Road, Manchester M6 8HD, UK; Department of Otolaryngology, The Richard Ramsden Centre for Hearing Implants, Peter Mount Building, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK.
Abstract:
Cochlear implantation offers significantly better hearing outcomes than auditory brainstem implantation in patients with vestibular schwannoma. Neither the primary treatment modality nor the cause of the tumor (neurofibromatosis type 2 related or sporadic) seems to have a significant effect on hearing outcome with cochlear implantation. Some uncertainty remains regarding long-term hearing outcomes; however, cochlear implantation in vestibular schwannoma serves to offer patients, with a functioning cochlear nerve, the probability of open set speech discrimination with a consequent positive impact on quality of life.
Related Concept Videos
Anatomy of the Ear
The Vestibular System

